Key Record Dates Identifier: NCT02942264
Brief Title: Zotiraciclib (TG02) Plus Dose-Dense or Metronomic Temozolomide Followed by Randomized Phase II Trial of Zotiraciclib (TG02) Plus Temozolomide Versus Temozolomide Alone in Adults With Recurrent Anaplastic Astrocytoma and Glioblastoma

First Submitted : October 21, 2016
First Submitted that Met QC Criteria : October 21, 2016
First Posted : October 24, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : March 26, 2021
Last Update Posted : March 29, 2021